Table IV.
HPLC analysis of paclitaxel | |||||
---|---|---|---|---|---|
Peak identity | R.R.T. | Standard | Sample 1 | Sample 2 | Sample 2a |
160 μg PAA | 160 μg PAA | 160 μg PAA30 minutes | |||
Total % | Total % | Total % | Total % | ||
Related compound B paclitaxel | 0.21 | 0.03 | 0.03 | 0.03 | 0.03 |
0.63 | 0.03 | ||||
0.81 | 0.34 | 0.33 | 0.34 | 0.34 | |
0.94 | 0.12 | 0.12 | 0.13 | 0.12 | |
1 | 100 | 100 | 100 | 100 | |
1.22 | 0.01 | ||||
1.42 | 0.08 | 0.06 | 0.06 | 0.06 | |
1.44 | 0.02 | ||||
1.65 | 0.09 | 0.08 | 0.11 | 0.09 | |
1.93 | 0.13 | 0.12 | 0.21 | 0.17 | |
2.75 | 0.02 | ||||
Total percent degradation products | 0.81 | 0.78 | 0.89 | 0.83 |
Peak areas reported as percent of paclitaxel peak. Samples 1 and 2 were two distinct samples dried on two separate days; sample 2a was dried in the same batch as sample 2, but included a 30-min incubation with PAA prior to initiating lyophobic precipitation; RRT relative retention time (relative to paclitaxel peak)